TGFB1 and neoplasm: Zuo et al. showed that the inhibition of TGF-b signalling pathway by the TGF-b type I receptor inhibitor LY364947 enhances the tumour penetration of the nanoparticles carrying siRNA targeting breast cancer stem cells.